Premature babies who are enrolled in clinical trials for therapies to treat and prevent complications from preterm birth are no more likely to die or experience poor outcomes than babies who are not trial participants, according to a retrospective analysis of more than 5,000 babies born before 29 weeks of gestation.![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
↧